Ohr Pharmaceuticals Revenue, Profits - OHRP Annual Income Statement

Add to My Stocks
$0.19 $0.01 (5.56%) OHRP stock closing price Sep 17, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Ohr Pharmaceuticals stock price. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from - to - and how operating and non operating activities have impacted the OHRP stock. The Ohr Pharmaceuticals profit and loss statement for 2017 shows a net profit of $-23.81M. Profits for last year was $-25.76M. Apart from this an investor should also check Ohr Pharmaceuticals assets and Ohr Pharmaceuticals free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Oct - Sep2017201620152014201320122011201020092008
Ohr Pharmaceuticals Revenues or Net Sales
----------
Cost Of Goods Sold (COGS)----------
Ohr Pharmaceuticals Gross Profit
----------
Research & Development Expense17.4M16.46M8.77M3.99M2.61M1.62M----
Selling General & Admin Expense5.2M6.94M7.5M5.13M2.01M1.66M----
Income Before Depreciation Depletion Amortization-22.61M-23.4M-16.28M-9.12M-4.62M-3.28M-1.24M-1.01M-0.93M-0.64M
Depreciation Depletion Amortization1.16M1.18M1.51M-------
Non Operating Income--1.18M2.61M--1.02M1.83M-3.85M1.53M--
Interest Expense--0.01M--------
Ohr Pharmaceuticals Pretax Income
-23.81M-25.76M-15.19M-9.13M-5.65M-1.45M-5.1M--0.86M-0.62M
Provision for Income Taxes----------
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-23.81M-25.76M-15.19M-9.13M-5.65M-1.45M-5.1M--0.86M-0.62M
Extraordinary Items & Discontinued Operations----------
Ohr Pharmaceuticals Profit/ Loss (Net Income)
-23.81M-25.76M-15.19M-9.13M-5.65M-1.45M-5.1M--0.86M-
Average Shares used to compute Diluted EPS44.91M31.35M28.4M22.14M------
Average Shares used to compute Basic EPS44.91M31.35M28.4M22.14M------
Income Before Nonrecurring Items-23.8M-25.77M-15.2M-9.13M------
Income from Nonrecurring Items----------
Ohr Pharmaceuticals Earnings Per Share Basic Net
-0.53-0.82-0.54-0.41-0.29-----
Ohr Pharmaceuticals Earnings Per Share Diluted Net
-0.53-0.82-0.54-0.41------
EPS Diluted Before Nonrecurring Items-0.53-0.82-0.54-0.41------
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Click here to view our Pfizer financial analysis

It is very helpful to read a report on Ohr Pharmaceuticals stock analysis. An investor must check the following items in an income statement:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $- for this year of 2017. Our Ohr Pharmaceuticals revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-23.81M for OHRP stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the OHRP income statement, one can check the Ohr Pharmaceuticals historical stock prices to check how the price has moved with time.

Ohr Pharmaceuticals Income Statement - Key Financial Ratios